Myelin Associated Glycoprotein (MAG) Antibody, IgM
Also known as: MAGM ELISA
Use
This test is used to identify elevated IgM antibody concentration against myelin-associated glycoprotein (MAG), which suggests active demyelination in peripheral neuropathy. It is a stand-alone test for autoimmune neuropathies and should be used alongside other clinical parameters for disease confirmation.
Special Instructions
Not provided.
Limitations
The test alone is not diagnostic and should be used in conjunction with other clinical parameters for a comprehensive assessment. The presence of MAG antibodies is indicative but not definitive for specific neuropathies, and results should be interpreted in a broader clinical context.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 17314-6
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.1 mL
Container
Serum separator tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated
Causes for Rejection
Urine. Contaminated, heat inactivated, hemolyzed, severely lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant